The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Breast Cancer Imaging Market Research Report 2024
Synopsis
The global Breast Cancer Imaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Breast Cancer Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Breast Cancer Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Breast Cancer Imaging in Diagnostic and imaging centers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Breast Cancer Imaging include GE Healthcare, Siemens Healthineers, Hologic, Philips Healthcare, Canon Medical, Fujifilm, CMR Naviscan, SonoCine and Dilon Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Breast Cancer Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Imaging.
Report Scope
The Breast Cancer Imaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Breast Cancer Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breast Cancer Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Siemens Healthineers
Hologic
Philips Healthcare
Canon Medical
Fujifilm
CMR Naviscan
SonoCine
Dilon Technologies
Segment by Type
Ionizing Technologies
Non-Ionizing Technologies
Segment by Application
Diagnostic and imaging centers
Hospitals and clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Imaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Breast Cancer Imaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Breast Cancer Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Breast Cancer Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Breast Cancer Imaging in Diagnostic and imaging centers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Breast Cancer Imaging include GE Healthcare, Siemens Healthineers, Hologic, Philips Healthcare, Canon Medical, Fujifilm, CMR Naviscan, SonoCine and Dilon Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Breast Cancer Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Imaging.
Report Scope
The Breast Cancer Imaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Breast Cancer Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breast Cancer Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Siemens Healthineers
Hologic
Philips Healthcare
Canon Medical
Fujifilm
CMR Naviscan
SonoCine
Dilon Technologies
Segment by Type
Ionizing Technologies
Non-Ionizing Technologies
Segment by Application
Diagnostic and imaging centers
Hospitals and clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Imaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Imaging Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Ionizing Technologies
1.2.3 Non-Ionizing Technologies
1.3 Market by Application
1.3.1 Global Breast Cancer Imaging Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic and imaging centers
1.3.3 Hospitals and clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Imaging Market Perspective (2019-2030)
2.2 Breast Cancer Imaging Growth Trends by Region
2.2.1 Global Breast Cancer Imaging Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Breast Cancer Imaging Historic Market Size by Region (2019-2024)
2.2.3 Breast Cancer Imaging Forecasted Market Size by Region (2025-2030)
2.3 Breast Cancer Imaging Market Dynamics
2.3.1 Breast Cancer Imaging Industry Trends
2.3.2 Breast Cancer Imaging Market Drivers
2.3.3 Breast Cancer Imaging Market Challenges
2.3.4 Breast Cancer Imaging Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Imaging Players by Revenue
3.1.1 Global Top Breast Cancer Imaging Players by Revenue (2019-2024)
3.1.2 Global Breast Cancer Imaging Revenue Market Share by Players (2019-2024)
3.2 Global Breast Cancer Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Imaging Revenue
3.4 Global Breast Cancer Imaging Market Concentration Ratio
3.4.1 Global Breast Cancer Imaging Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Imaging Revenue in 2023
3.5 Breast Cancer Imaging Key Players Head office and Area Served
3.6 Key Players Breast Cancer Imaging Product Solution and Service
3.7 Date of Enter into Breast Cancer Imaging Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Imaging Breakdown Data by Type
4.1 Global Breast Cancer Imaging Historic Market Size by Type (2019-2024)
4.2 Global Breast Cancer Imaging Forecasted Market Size by Type (2025-2030)
5 Breast Cancer Imaging Breakdown Data by Application
5.1 Global Breast Cancer Imaging Historic Market Size by Application (2019-2024)
5.2 Global Breast Cancer Imaging Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Breast Cancer Imaging Market Size (2019-2030)
6.2 North America Breast Cancer Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Breast Cancer Imaging Market Size by Country (2019-2024)
6.4 North America Breast Cancer Imaging Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Breast Cancer Imaging Market Size (2019-2030)
7.2 Europe Breast Cancer Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Breast Cancer Imaging Market Size by Country (2019-2024)
7.4 Europe Breast Cancer Imaging Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Imaging Market Size (2019-2030)
8.2 Asia-Pacific Breast Cancer Imaging Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Breast Cancer Imaging Market Size by Region (2019-2024)
8.4 Asia-Pacific Breast Cancer Imaging Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Breast Cancer Imaging Market Size (2019-2030)
9.2 Latin America Breast Cancer Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Breast Cancer Imaging Market Size by Country (2019-2024)
9.4 Latin America Breast Cancer Imaging Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Imaging Market Size (2019-2030)
10.2 Middle East & Africa Breast Cancer Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Breast Cancer Imaging Market Size by Country (2019-2024)
10.4 Middle East & Africa Breast Cancer Imaging Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Breast Cancer Imaging Introduction
11.1.4 GE Healthcare Revenue in Breast Cancer Imaging Business (2019-2024)
11.1.5 GE Healthcare Recent Development
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Company Detail
11.2.2 Siemens Healthineers Business Overview
11.2.3 Siemens Healthineers Breast Cancer Imaging Introduction
11.2.4 Siemens Healthineers Revenue in Breast Cancer Imaging Business (2019-2024)
11.2.5 Siemens Healthineers Recent Development
11.3 Hologic
11.3.1 Hologic Company Detail
11.3.2 Hologic Business Overview
11.3.3 Hologic Breast Cancer Imaging Introduction
11.3.4 Hologic Revenue in Breast Cancer Imaging Business (2019-2024)
11.3.5 Hologic Recent Development
11.4 Philips Healthcare
11.4.1 Philips Healthcare Company Detail
11.4.2 Philips Healthcare Business Overview
11.4.3 Philips Healthcare Breast Cancer Imaging Introduction
11.4.4 Philips Healthcare Revenue in Breast Cancer Imaging Business (2019-2024)
11.4.5 Philips Healthcare Recent Development
11.5 Canon Medical
11.5.1 Canon Medical Company Detail
11.5.2 Canon Medical Business Overview
11.5.3 Canon Medical Breast Cancer Imaging Introduction
11.5.4 Canon Medical Revenue in Breast Cancer Imaging Business (2019-2024)
11.5.5 Canon Medical Recent Development
11.6 Fujifilm
11.6.1 Fujifilm Company Detail
11.6.2 Fujifilm Business Overview
11.6.3 Fujifilm Breast Cancer Imaging Introduction
11.6.4 Fujifilm Revenue in Breast Cancer Imaging Business (2019-2024)
11.6.5 Fujifilm Recent Development
11.7 CMR Naviscan
11.7.1 CMR Naviscan Company Detail
11.7.2 CMR Naviscan Business Overview
11.7.3 CMR Naviscan Breast Cancer Imaging Introduction
11.7.4 CMR Naviscan Revenue in Breast Cancer Imaging Business (2019-2024)
11.7.5 CMR Naviscan Recent Development
11.8 SonoCine
11.8.1 SonoCine Company Detail
11.8.2 SonoCine Business Overview
11.8.3 SonoCine Breast Cancer Imaging Introduction
11.8.4 SonoCine Revenue in Breast Cancer Imaging Business (2019-2024)
11.8.5 SonoCine Recent Development
11.9 Dilon Technologies
11.9.1 Dilon Technologies Company Detail
11.9.2 Dilon Technologies Business Overview
11.9.3 Dilon Technologies Breast Cancer Imaging Introduction
11.9.4 Dilon Technologies Revenue in Breast Cancer Imaging Business (2019-2024)
11.9.5 Dilon Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
